Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for Postoperative Pain in Foot Surgery
NCT02499575Terminated
- Sponsor
- OhioHealth
- Start
- Jul 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by OhioHealth. Primary endpoints: Opioid Use as Measured by Questionnaire and Total Opioid Use as Measured by Questionnaire at 72 hours. Started Jul 2015; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02499575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02499575.